Stomach Cancer News and Research RSS Feed - Stomach Cancer News and Research

Stomach cancer or gastric cancer affects around 7,000 people each year in the UK. Stomach cancer is difficult to detect in the early stages because the initial symptoms are also seen in less serious conditions such as persistent indigestion, heart burn, trapped wind, burping and stomach ache.
FDA grants Priority Review to Lilly's ramucirumab for treatment of advanced gastric cancer

FDA grants Priority Review to Lilly's ramucirumab for treatment of advanced gastric cancer

Eli Lilly and Company today announced that the U.S. Food and Drug Administration has assigned Priority Review to the regulatory submission for ramucirumab (IMC-1121B) as a single-agent treatment for advanced gastric cancer following disease progression after initial chemotherapy. [More]
UCSD surgeons perform first robotic gastrectomy for gastric cancer treatment

UCSD surgeons perform first robotic gastrectomy for gastric cancer treatment

Surgeons at UC San Diego Health System have performed the region's first robotic gastrectomy, a potentially lifesaving procedure to remove a section of the stomach after a diagnosis of gastric cancer. Aided by a da Vinci robot, surgeons remove the diseased tissue, perform a delicate reconstruction and remove local lymph nodes for further testing. [More]
Study shows how stomach bacteria manipulates human immune system to survive in stomach

Study shows how stomach bacteria manipulates human immune system to survive in stomach

Helicobacter pylori is a bacterium that establishes a life-long stomach infection in humans, which in some cases can lead to duodenal ulcers or stomach cancer. New research, presented at this week's Society for General Microbiology Autumn Conference, gives us a clearer understanding of how these bacteria can manipulate the human immune system to survive in the mucosal lining of the stomach. [More]
Study shows genetic test to classify gastric cancers and match them to therapies offer best outcomes

Study shows genetic test to classify gastric cancers and match them to therapies offer best outcomes

Stomach cancer, one of the leading causes of cancer death worldwide, actually falls into three broad subtypes that respond differently to currently available therapies, according to researchers at Duke-NUS Graduate Medical School Singapore. [More]
Certain Hodgkin lymphoma treatments put patients at increased risk for stomach cancer

Certain Hodgkin lymphoma treatments put patients at increased risk for stomach cancer

Hodgkin lymphoma survivors who received certain radiation and chemotherapy regimens were at increased risk of subsequently developing stomach cancer, according to a study by scientists at the National Cancer Institute, part of the National Institutes of Health. [More]
AGA acknowledges partnership of GCF to support research in gastric, esophageal cancer

AGA acknowledges partnership of GCF to support research in gastric, esophageal cancer

The American Gastroenterological Association (AGA) Research Foundation is pleased to announce that it has partnered with the Gastric Cancer Foundation (GCF) to create a new grant to support research in gastric and esophageal cancer. [More]
UCLA receives $5M from NIH to develop tool for detecting stomach cancer

UCLA receives $5M from NIH to develop tool for detecting stomach cancer

​Imagine having a sample of your saliva taken at the dentist's office, and then learning within minutes whether your risk for stomach cancer is higher than normal. That futuristic-sounding scenario may actually not be too far from reality. [More]
Publication of death rates: an interview with Dr Kate Walker, London School of Hygiene and Tropical Medicine

Publication of death rates: an interview with Dr Kate Walker, London School of Hygiene and Tropical Medicine

The death rates of individual heart surgeons have been published in England and several US states for some years. A high profile investigation into high death rates at a certain cardiac centre motivated this in England. For other surgery types, death rates have been reported only at the hospital or trust level. NHS England’s “Everyone Counts” policy, introduced this Summer, means that outcomes of ten types of surgery will be reported at the individual surgeon level. [More]
ImmunoGen reports net loss of $21.9 million in Q4 2013

ImmunoGen reports net loss of $21.9 million in Q4 2013

ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload antibody-drug conjugate technology, today reported financial results for the three-month period and fiscal year ended June 30, 2013. ImmunoGen also provided guidance for its 2014 fiscal year and an update on the Company. [More]
White blood cells and the spread of cancer: an interview with Drs. Lorenzo Ferri and Jonathan Cools-Lartigue, McGill University

White blood cells and the spread of cancer: an interview with Drs. Lorenzo Ferri and Jonathan Cools-Lartigue, McGill University

As surgeons who take care of cancer patients, we have observed a troubling association between patients who suffer from infections after surgery and the rapid spread of their cancer. We have reported this in lung cancer patients, and others have made these observations in a variety of different cancers. However, the mechanisms responsible for this association are still poorly understood. [More]
Exalenz Bioscience launches BreathID Hp to test and treat H. pylori

Exalenz Bioscience launches BreathID Hp to test and treat H. pylori

Exalenz Bioscience, developer of advanced diagnostic systems that use a patient's breath to detect and help manage gastrointestinal and liver conditions, announced today the global launch of the BreathID Hp, a next generation device in the company's BreathID product line. [More]
It is possible to reduce salt content without reducing the taste

It is possible to reduce salt content without reducing the taste

It is entirely possible to reduce the salt content in a range of foods by up to 30% without reducing the taste. [More]
Genetic loci associated with H pylori bacteria are linked to stomach cancer

Genetic loci associated with H pylori bacteria are linked to stomach cancer

Two genome-wide association studies and a subsequent meta-analysis have found that certain genetic variations are associated with susceptibility to Helicobacter pylori, a bacteria that is a major cause of gastritis and stomach ulcers and is linked to stomach cancer, findings that may help explain some of the observed variation in individual risk for H pylori infection, according to a study in the May 8 issue of JAMA. [More]
Research findings have potential implications for treating human infections

Research findings have potential implications for treating human infections

Half of the world's human population is infected with the stomach bacteria called Helicobacter pylori, yet it causes disease in only about 10 percent of those infected. Other bacteria living in the stomach may be a key factor in whether or not H. pylori causes disease, according to a new study led by scientists at the University of California, Santa Cruz. [More]
Technique breathes new life into gastric cancer diagnosis

Technique breathes new life into gastric cancer diagnosis

A nanomaterial breath test can accurately distinguish gastric cancer from benign stomach disorders, preliminary results show. [More]
Weekend reading: Navigating treatment; Can a robot replace your doctor?

Weekend reading: Navigating treatment; Can a robot replace your doctor?

Your pathology report indicates that you have stomach cancer. Hearing those words conveying yet another cancer-related diagnosis-;my fourth since the age of 20-;I felt, at the age of 57, as though I had been airdropped into a foreign country. [More]
Scientists discover new subgroups of GC patients with different disease's characteristics

Scientists discover new subgroups of GC patients with different disease's characteristics

A collaboration between Portuguese and Italian scientists has discovered new subgroups of stomach cancer patients with different disease's characteristics, an information that is hoped will help improving the clinical management of a disease that still kills a dismaying 3 out of 4 patients. [More]
Case Western Reserve receives $220,000 grant to study gastric cancers

Case Western Reserve receives $220,000 grant to study gastric cancers

The Case Western Reserve University School of Medicine has received a $220,000 grant from the DeGregorio Family Foundation to study gastric cancers, which remain among the most deadly forms of disease. [More]
UCSD molecular biologist to receive Charles Rodolphe Brupbacher Prize for Cancer Research

UCSD molecular biologist to receive Charles Rodolphe Brupbacher Prize for Cancer Research

Molecular biologist Michael Karin is to receive this year's Charles Rodolphe Brupbacher Prize for Cancer Research in recognition of his studies on the role of chronic inflammation in the development of tumors. The award, which carries CHF 100,000 in prize money, is considered one of the highest accolades for cancer researchers worldwide. The awards ceremony takes place in Zurich this Thursday in the framework of an international symposium on "Breakthroughs in Cancer Research and Therapy". [More]
Gastrointestinal Cancers Symposium to be held from Jan. 24-26 in San Francisco, CA

Gastrointestinal Cancers Symposium to be held from Jan. 24-26 in San Francisco, CA

New research into the treatment and prognosis of gastrointestinal cancers was released today in advance of the tenth annual Gastrointestinal Cancers Symposium being held January 24-26, 2013, at The Moscone West Building in San Francisco, CA. [More]